Method Development and Validation of Ciprofloxacin HCl and Ornidazole by UFLC in Combined Dosage Form

ABSTRACT

Background: The combination of Ciprofloxacin and Ornidazole is used for the effective treatment of intra-abdominal infections. Many branded and generic combined dosage formulations of Ciprofloxacin and Ornidazole are available in market. Objective: To develop and validate rapid, sensitive, simple and accurate reverse phase ultra-fast liquid chromatographic method for the determination of Ciprofloxacin and Ornidazole in combined dosage forms. Methods: The separation was carried out by using Phenomenex Luna C18 (250×4.6 mm, 5 µm) column as stationary phase and acetonitrile: methanol: 0.1% formic acid as a mobile phase in ratio of 35:35:30 % v/v/v. The analysis was performed at flow rate of 0.8 ml/min using PDA detector at 300 nm. The column temperature was maintained at 20°C for better separation and resolution. Results: The retention time for Ciprofloxacin HCl and Ornidazole was found to be 2.1 min and 4.2 min respectively. The developed method was validated with respect to specificity, linearity and range, precision, robustness and accuracy according to ICH guidelines. The method was found to be linear between the concentration ranges of 2-10 µg/ml with correlation coefficient of 0.999. The % relative standard deviation of precision and robustness was found to be less than 2%. The percent accuracy was found to be 98-103% and 99-102% for Ciprofloxacin HCl and Ornidazole respectively. Conclusion: The method is applicable for the routine analysis and quality control of Ciprofloxacin HCl and Ornidazole in combination.

KEYWORDS

• Ciprofloxacin HCl
• Ornidazole
• Intra-abdominal infections
• Ultra-fast
• PDA
• detector

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.53.3s.108Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 53, ISSUE 3SSystematic Development with Quality by Design Approach of Effervescent Floating Multiple Unit Minitablets of Metoprolol Succinate using Hydrophobic Grade of GelucireSantosh Kumar Panda, Manoranjan Sahu, Kahnu Charan Panigrahi, Chinam Niranjan Patra · pp. s213–s224Original ArticleSame type: Article
• Article · VOLUME 53, ISSUE 3SExperimental Data of Fabricated Co-crystals of Doxorubicin HCl with FlavonoidsPrasanna Laxmi, Abhishek Varma, Aravind Pai, Muddukrishna Badamane Sathyanarayana · pp. s225–s230Original ArticleSame type: Article
• Article · VOLUME 53, ISSUE 3SSolubility Augmentation of Simvastatin by using the Marvelous Carrier Hydroxy Propyl β-cyclodextrin: Compatibility Study, Statistical and Spectral AnalysisDisha Kesharwani, Sandhya Mishra, Swarnali Das Paul, Rishi Paliwal, Trilochan Satapathy · pp. s231–s238Original ArticleSame type: Article
• Article · VOLUME 53, ISSUE 3SAn Innovative Approach in Developing Sustained Release Matrix Tablets using Isolated and Characterized Novel Ceasalpinia sappan L. Seed GalactomannanShan Mohanan, Sajan Jose · pp. s239–s245Original ArticleSame type: Article